
Intended Use
in vitro diagnostic medical device that helps blood analysis by quantifying sdLDL-C (small dense Low Density Lipoprotein-Cholesterol) in human serum by Enzymatic method.
* New Health Technology Assessment
The technology “sdLDL Cholesterol Test” was reported as a safe and effective technique for predicting and assessing the risk of major cardiovascular events(MACEs). (Ministry of Health and Welfare Notice No. 2022-196, August 18, 2022)
Product Information
Assay principle |
Enzymatic method |
Sample |
Serum |
Storage conditions |
2 ~ 8 ℃ |
Approval No. |
21 - 4967 |
Order Information
Products |
Cat No. |
Composition |
GeneX sdLDL-C R1 |
GXS1007A |
30mL x 1 Vial |
GeneX sdLDL-C R2 |
10mL x 1 Vial |
GeneX sdLDL-C R1 |
GXS1007B |
15mL x 1 Vial |
GeneX sdLDL-C R2 |
5mL x 1 Vial |
GeneX sdLDL-C Calibrator |
GXC5013A |
1mL x 1 Conc. x 1 Vial |
GeneX sdLDL-C Control |
GXC5014A |
1mL x 2 Conc. x 1 Vial |
This product is an “in vitro diagnostic medical device”, please refer to “Precautions for use”and “Instructions for use”.